Pacific Biosciences of California, Inc. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
Pacific Biosciences of California, Inc. (PACB) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $97.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2026-08-06
- Pacific Biosciences of California, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-06-30 was $48.78M, a 40.51% decline year-over-year.
- Pacific Biosciences of California, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-03-31 was $48.25M, a 57.47% decline year-over-year.
- Pacific Biosciences of California, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-12-31 was $59.98M, a 47.17% decline year-over-year.
- Pacific Biosciences of California, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-09-30 was $84.64M, a 34.29% decline year-over-year.
- Pacific Biosciences of California, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2025 was $340.07M, a 42.75% decline from fiscal 2024.
- Pacific Biosciences of California, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2024 was $593.97M, a 22.81% decline from fiscal 2023.
- Pacific Biosciences of California, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2023 was $769.52M, a 33.64% increase from fiscal 2022.
- Pacific Biosciences of California, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2022 was $575.80M, a 36.28% increase from fiscal 2021.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $48.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $97.03M 10-Q · filed 2026-08-06 | $157.01M derived: sum of 3 quarters · filed 2026-08-06 | $241.66M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $48.25M 10-Q · filed 2026-05-08 | $108.23M derived: sum of 2 quarters · filed 2026-05-08 | $192.88M derived: sum of 3 quarters · filed 2026-05-08 | $274.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $59.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $144.63M derived: sum of 2 quarters · filed 2026-02-25 | $226.63M derived: sum of 3 quarters · filed 2026-08-06 | $340.07M 10-K · filed 2026-02-25 |
| 2025-09-30 | $84.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $166.65M derived: sum of 2 quarters · filed 2026-08-06 | $280.09M 10-Q · filed 2025-11-06 | $393.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $82.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $195.45M 10-Q · filed 2026-08-06 | $308.98M derived: sum of 3 quarters · filed 2026-08-06 | $437.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $113.44M 10-Q · filed 2026-05-08 | $226.97M derived: sum of 2 quarters · filed 2026-05-08 | $355.79M derived: sum of 3 quarters · filed 2026-05-08 | $545.76M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $113.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $242.35M derived: sum of 2 quarters · filed 2026-02-25 | $432.32M derived: sum of 3 quarters · filed 2026-02-25 | $593.97M 10-K · filed 2026-02-25 |
| 2024-09-30 | $128.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $318.79M derived: sum of 2 quarters · filed 2025-11-06 | $480.44M 10-Q · filed 2025-11-06 | $618.71M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $189.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $351.62M 10-Q · filed 2025-08-07 | $489.89M derived: sum of 3 quarters · filed 2026-02-25 | $810.01M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $161.65M 10-Q · filed 2025-05-12 | $299.92M derived: sum of 2 quarters · filed 2026-02-25 | $620.04M derived: sum of 3 quarters · filed 2026-02-25 | $767.31M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $138.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $458.39M derived: sum of 2 quarters · filed 2026-02-25 | $605.66M derived: sum of 3 quarters · filed 2026-02-25 | $769.52M 10-K · filed 2026-02-25 |
| 2023-09-30 | $320.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $467.39M derived: sum of 2 quarters · filed 2024-11-12 | $631.25M 10-Q · filed 2024-11-12 | $851.63M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $147.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $311.13M 10-Q · filed 2024-08-09 | $531.50M derived: sum of 3 quarters · filed 2025-03-17 | $656.41M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $163.86M 10-Q · filed 2024-05-09 | $384.24M derived: sum of 2 quarters · filed 2025-03-17 | $509.15M derived: sum of 3 quarters · filed 2025-03-17 | $617.60M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $220.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $345.29M derived: sum of 2 quarters · filed 2025-03-17 | $453.74M derived: sum of 3 quarters · filed 2025-03-17 | $575.80M 10-K · filed 2025-03-17 |
| 2022-09-30 | $124.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $233.37M derived: sum of 2 quarters · filed 2023-11-03 | $355.43M 10-Q · filed 2023-11-03 | $554.64M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $108.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $230.51M 10-Q · filed 2023-08-04 | $429.74M derived: sum of 3 quarters · filed 2024-02-28 | $502.85M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $122.06M 10-Q · filed 2023-05-04 | $321.28M derived: sum of 2 quarters · filed 2024-02-28 | $394.39M derived: sum of 3 quarters · filed 2024-02-28 | $476.17M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $199.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $272.33M derived: sum of 2 quarters · filed 2024-02-28 | $354.11M derived: sum of 3 quarters · filed 2024-02-28 | $422.50M 10-K · filed 2024-02-28 |
| 2021-09-30 | $73.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $154.88M derived: sum of 2 quarters · filed 2022-11-08 | $223.28M 10-Q · filed 2022-11-08 | $262.19M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $81.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $150.18M 10-Q · filed 2022-08-08 | $189.07M derived: sum of 3 quarters · filed 2023-02-28 | $241.32M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $68.40M 10-Q · filed 2022-05-06 | $107.30M derived: sum of 2 quarters · filed 2023-02-28 | $159.55M derived: sum of 3 quarters · filed 2023-02-28 | $203.25M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $38.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $91.15M derived: sum of 2 quarters · filed 2023-02-28 | $134.85M derived: sum of 3 quarters · filed 2023-02-28 | $153.60M 10-K · filed 2023-02-28 |
| 2020-09-30 | $52.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $95.95M derived: sum of 2 quarters · filed 2021-11-05 | $114.70M 10-Q · filed 2021-11-05 | $126.45M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $43.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $62.45M 10-Q · filed 2021-08-06 | $74.20M derived: sum of 3 quarters · filed 2022-02-28 | $99.15M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $18.75M 10-Q · filed 2021-05-06 | $30.50M derived: sum of 2 quarters · filed 2022-02-28 | $55.45M derived: sum of 3 quarters · filed 2022-02-28 | $83.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $11.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $36.70M derived: sum of 2 quarters · filed 2022-02-28 | $64.25M derived: sum of 3 quarters · filed 2022-02-28 | $121.11M 10-K · filed 2022-02-28 |
| 2019-09-30 | $24.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $52.50M derived: sum of 2 quarters · filed 2020-11-03 | $109.36M 10-Q · filed 2020-11-03 | $121.86M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $27.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $84.41M 10-Q · filed 2020-08-06 | $96.91M derived: sum of 3 quarters · filed 2021-02-26 | $119.39M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $56.86M 10-Q · filed 2020-05-08 | $69.36M derived: sum of 2 quarters · filed 2021-02-26 | $91.84M derived: sum of 3 quarters · filed 2021-02-26 | $118.34M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $12.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $34.98M derived: sum of 2 quarters · filed 2021-02-26 | $61.48M derived: sum of 3 quarters · filed 2021-02-26 | $83.18M 10-K · filed 2021-02-26 |
| 2018-09-30 | $22.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $48.98M derived: sum of 2 quarters · filed 2019-11-07 | $70.68M 10-Q · filed 2019-11-07 | $90.68M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $26.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $48.20M 10-Q · filed 2019-08-06 | $68.20M derived: sum of 3 quarters · filed 2020-02-28 | $89.76M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $21.70M 10-Q · filed 2019-05-03 | $41.70M derived: sum of 2 quarters · filed 2020-02-28 | $63.26M derived: sum of 3 quarters · filed 2020-02-28 | $74.87M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $41.56M derived: sum of 2 quarters · filed 2020-02-28 | $53.17M derived: sum of 3 quarters · filed 2020-02-28 | $88.07M 10-K · filed 2020-02-28 |
| 2017-09-30 | $21.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $33.17M derived: sum of 2 quarters · filed 2018-11-05 | $68.07M 10-Q · filed 2018-11-05 | $87.76M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $11.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $46.51M 10-Q · filed 2018-08-03 | $66.20M derived: sum of 3 quarters · filed 2019-02-26 | $90.33M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $34.91M 10-Q · filed 2018-05-02 | $54.59M derived: sum of 2 quarters · filed 2019-02-26 | $78.72M derived: sum of 3 quarters · filed 2019-02-26 | $85.26M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $19.69M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $43.81M derived: sum of 2 quarters · filed 2019-02-26 | $50.36M derived: sum of 3 quarters · filed 2019-02-26 | $65.90M 10-K · filed 2019-02-26 |
| 2016-09-30 | $24.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $30.67M derived: sum of 2 quarters · filed 2017-11-02 | $46.21M 10-Q · filed 2017-11-02 | $70.00M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $6.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $22.08M 10-Q · filed 2017-08-02 | $45.87M derived: sum of 3 quarters · filed 2018-02-26 | $62.52M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $15.54M 10-Q · filed 2017-05-05 | $39.33M derived: sum of 2 quarters · filed 2018-02-26 | $55.98M derived: sum of 3 quarters · filed 2018-02-26 | $73.42M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $23.79M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $40.44M derived: sum of 2 quarters · filed 2018-02-26 | $57.88M derived: sum of 3 quarters · filed 2018-02-26 | $92.34M 10-K · filed 2018-02-26 |
| 2015-09-30 | $16.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $34.09M derived: sum of 2 quarters · filed 2016-11-04 | $68.55M 10-Q · filed 2016-11-04 | $96.47M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $17.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $51.90M 10-Q · filed 2016-08-04 | $79.81M derived: sum of 3 quarters · filed 2017-03-06 | $123.29M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $34.46M 10-Q · filed 2016-05-05 | $62.38M derived: sum of 2 quarters · filed 2017-03-06 | $105.86M derived: sum of 3 quarters · filed 2017-03-06 | $136.86M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $27.91M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $71.39M derived: sum of 2 quarters · filed 2017-03-06 | $102.40M derived: sum of 3 quarters · filed 2017-03-06 | $147.59M 10-K · filed 2017-03-06 |
| 2014-09-30 | $43.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $74.48M derived: sum of 2 quarters · filed 2015-11-05 | $119.67M 10-Q · filed 2015-11-05 | $155.52M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $31.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $76.19M 10-Q · filed 2015-08-05 | $112.04M derived: sum of 3 quarters · filed 2016-03-11 | $146.06M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $45.19M 10-Q · filed 2015-05-05 | $81.04M derived: sum of 2 quarters · filed 2016-03-11 | $115.06M derived: sum of 3 quarters · filed 2016-03-11 | $177.25M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $35.85M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $69.87M derived: sum of 2 quarters · filed 2016-03-11 | $132.06M derived: sum of 3 quarters · filed 2016-03-11 | $169.24M 10-K · filed 2016-03-11 |
| 2013-09-30 | $34.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $96.21M derived: sum of 2 quarters · filed 2014-11-05 | $133.39M 10-Q · filed 2014-11-05 | $184.49M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $62.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $99.37M 10-Q · filed 2014-08-05 | $150.47M derived: sum of 3 quarters · filed 2015-03-12 | $178.89M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $37.18M 10-Q · filed 2014-05-08 | $88.28M derived: sum of 2 quarters · filed 2015-03-12 | $116.70M derived: sum of 3 quarters · filed 2015-03-12 | $150.78M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $51.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $79.52M derived: sum of 2 quarters · filed 2015-03-12 | $113.60M derived: sum of 3 quarters · filed 2015-03-12 | $143.49M 10-K · filed 2015-03-12 |
| 2012-09-30 | $28.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $62.50M derived: sum of 2 quarters · filed 2013-11-12 | $92.39M 10-Q · filed 2013-11-12 | $140.74M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $34.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $63.97M 10-Q · filed 2013-08-09 | $112.32M derived: sum of 3 quarters · filed 2014-03-14 | $181.97M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $29.89M 10-Q · filed 2013-05-10 | $78.24M derived: sum of 2 quarters · filed 2014-03-14 | $147.88M derived: sum of 3 quarters · filed 2014-03-14 | $224.38M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $48.35M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $118.00M derived: sum of 2 quarters · filed 2014-03-14 | $194.50M derived: sum of 3 quarters · filed 2014-03-14 | $243.28M 10-K · filed 2014-03-14 |
| 2011-09-30 | $69.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $146.14M derived: sum of 2 quarters · filed 2012-11-01 | $194.93M 10-Q · filed 2012-11-01 | $213.29M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $76.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $125.28M 10-Q · filed 2012-08-07 | $143.65M derived: sum of 3 quarters · filed 2013-03-15 | $169.76M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $48.78M 10-Q · filed 2012-05-07 | $67.15M derived: sum of 2 quarters · filed 2013-03-15 | $93.26M derived: sum of 3 quarters · filed 2013-03-15 | |
| 2010-12-31 | $18.37M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $44.47M derived: sum of 2 quarters · filed 2013-03-15 | $47.97M 10-K · filed 2013-03-15 | |
| 2010-09-30 | $26.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $29.61M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $3.50M 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $49.20M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |